336 related articles for article (PubMed ID: 16302850)
1. In situ-produced 7-chlorokynurenate has different effects on evoked responses in rats with limbic epilepsy in comparison to naive controls.
Zhang DX; Williamson JM; Wu HQ; Schwarcz R; Bertram EH
Epilepsia; 2005 Nov; 46(11):1708-15. PubMed ID: 16302850
[TBL] [Abstract][Full Text] [Related]
2. Kynurenate and 7-chlorokynurenate formation in chronically epileptic rats.
Wu HQ; Rassoulpour A; Goodman JH; Scharfman HE; Bertram EH; Schwarcz R
Epilepsia; 2005 Jul; 46(7):1010-6. PubMed ID: 16026552
[TBL] [Abstract][Full Text] [Related]
3. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
Guidetti P; Wu HQ; Schwarcz R
Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450
[TBL] [Abstract][Full Text] [Related]
4. Selectivity of quinoxalines and kynurenines as antagonists of the glycine site on N-methyl-D-aspartate receptors.
Kleckner NW; Dingledine R
Mol Pharmacol; 1989 Sep; 36(3):430-6. PubMed ID: 2550776
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of 5-HT(1A) receptors in the dorsal raphe ameliorates the impairment of spatial learning caused by intrahippocampal 7-chloro-kynurenic acid in naive and pretrained rats.
Carli M; Balducci C; Samanin R
Psychopharmacology (Berl); 2001 Oct; 158(1):39-47. PubMed ID: 11685382
[TBL] [Abstract][Full Text] [Related]
6. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.
Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S
Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203
[TBL] [Abstract][Full Text] [Related]
7. Is endogenous D-serine in the rostral anterior cingulate cortex necessary for pain-related negative affect?
Ren WH; Guo JD; Cao H; Wang H; Wang PF; Sha H; Ji RR; Zhao ZQ; Zhang YQ
J Neurochem; 2006 Mar; 96(6):1636-47. PubMed ID: 16476080
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological characterisation of the actions of kynurenic acid at ligand-gated ion channels.
Mok MH; Fricker AC; Weil A; Kew JN
Neuropharmacology; 2009 Sep; 57(3):242-9. PubMed ID: 19523966
[TBL] [Abstract][Full Text] [Related]
9. Taurine potentiates presynaptic NMDA receptors in hippocampal Schaffer collateral axons.
Suárez LM; Solís JM
Eur J Neurosci; 2006 Jul; 24(2):405-18. PubMed ID: 16836643
[TBL] [Abstract][Full Text] [Related]
10. Glycine site associated with the NMDA receptor modulates long-term potentiation.
Oliver MW; Kessler M; Larson J; Schottler F; Lynch G
Synapse; 1990; 5(4):265-70. PubMed ID: 2163119
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the Effects of L-4-Chlorokynurenine on Nociception in Rodents.
Yaksh TL; Schwarcz R; Snodgrass HR
J Pain; 2017 Oct; 18(10):1184-1196. PubMed ID: 28428091
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-catalyzed production of the neuroprotective NMDA receptor antagonist 7-chlorokynurenic acid in the rat brain in vivo.
Wu HQ; Salituro FG; Schwarcz R
Eur J Pharmacol; 1997 Jan; 319(1):13-20. PubMed ID: 9030892
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors.
Hayashi Y; Ishibashi H; Hashimoto K; Nakanishi H
Glia; 2006 Apr; 53(6):660-8. PubMed ID: 16498631
[TBL] [Abstract][Full Text] [Related]
14. Quantitative differences in the effects of de novo produced and exogenous kynurenic acid in rat brain slices.
Scharfman HE; Hodgkins PS; Lee SC; Schwarcz R
Neurosci Lett; 1999 Oct; 274(2):111-4. PubMed ID: 10553950
[TBL] [Abstract][Full Text] [Related]
15. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
[TBL] [Abstract][Full Text] [Related]
16. Different reactions of control and epileptic rats to administration of APV or muscimol on thalamic or CA3-induced CA1 responses.
Zhang DX; Bertram EH
J Neurophysiol; 2003 Nov; 90(5):2875-83. PubMed ID: 12917381
[TBL] [Abstract][Full Text] [Related]
17. Glycine binding sites of presynaptic NMDA receptors may tonically regulate glutamate release in the rat visual cortex.
Li YH; Han TZ
J Neurophysiol; 2007 Jan; 97(1):817-23. PubMed ID: 17093111
[TBL] [Abstract][Full Text] [Related]
18. Tonic facilitation of glutamate release by glycine binding sites on presynaptic NR2B-containing NMDA autoreceptors in the rat visual cortex.
Li YH; Han TZ; Meng K
Neurosci Lett; 2008 Feb; 432(3):212-6. PubMed ID: 18248890
[TBL] [Abstract][Full Text] [Related]
19. Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance.
Danysz W; Kozela E; Parsons CG; Sladek M; Bauer T; Popik P
Neuropharmacology; 2005 Mar; 48(3):360-71. PubMed ID: 15721168
[TBL] [Abstract][Full Text] [Related]
20. Late N-methyl-D-aspartate receptor blockade rescues hippocampal neurons from excitotoxic stress and death after 4-aminopyridine-induced epilepsy.
Ayala GX; Tapia R
Eur J Neurosci; 2005 Dec; 22(12):3067-76. PubMed ID: 16367773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
